Clinical Trial Update: Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

View source ↗

Summary

This clinical trial update describes a completed study that evaluated breast density, hormone levels, and anticancer drug levels in women with invasive breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Aromasin (exemestane)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Status: COMPLETED